What we achieved in 2025, together
Date
Research news
Date
A pioneering clinical trial will investigate if cannabidiol (CBD) – a compound found in the cannabis plant – can treat hallucinations and delusions in people living with Parkinson’s.
Date
A phase II clinical trial of tavapadon, a drug developed by Cerevel Therapeutics, has shown improvements in movement symptoms. The results have been announced on the company website.
Date
Researchers have shown that those taking part in a home-based exercise programme experienced improvements in their motor symptoms.
Date
A drug used to treat enlarged prostates may have exciting potential for slowing down Parkinson's, according to research published in the Journal of Clinical Investigation.
Date
Researchers have shown that boosting levels of oestrogen in the brains of mice improved symptoms by slowing the build-up of the toxic protein alpha-synuclein.
Date
In a seminal research paper, published in Lancet Neurology, researchers from King’s College London have used brain scans to uncover early changes in the brain that may happen years before the symptoms of Parkinson's appear.
Date
Researchers in the US have identified a protein in the brain that may reduce the spread of the toxic alpha-synuclein protein in Parkinson's.
Date
Researchers at King's College London have investigated the properties of over 1,000 approved drugs to identify 2 with potential for Parkinson's.
Date
The results indicate that, when given early, the molecule Anle138b may restore dopamine levels and help slow or stop Parkinson’s in its tracks.
Date
Researchers in the US have launched a clinical trial to test a drug with the potential to slow the progression of Lewy body dementia.